The

n e w e ng l a n d j o u r na l

package of interventions. The effectiveness of this treatment approach will need to be validated with clinical research at other Ebola treatment facilities. All data were collected under government mandate as part of an active public health surveillance initiative. The data included in this letter were anonymized before analysis.

Rashid Ansumana, M.Sc. Mercy Hospital Research Laboratory Bo, Sierra Leone

Kathryn H. Jacobsen, Ph.D., M.P.H. George Mason University Fairfax, VA [email protected]

Foday Sahr, M.B., Ch.B., D. Sc. 34 Military Hospital at Wilberforce Freetown, Sierra Leone

and Others A complete list of authors is available with the full text of this letter at NEJM.org. Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.

of

m e dic i n e

Society, its licensees, and its assignees to use it in the Journal’s various print and electronic publications and in collections, revisions, and any other form or medium.

corrections A New Era for the Treatment of Hyperkalemia? (January 15, 2015;372:275-7). In the first paragraph (page 275), the first sentence should have given the potassium concentration within human cells as approximately 140 mmol per liter, rather than 70 mmol per liter. In the reference list (page 277), the authors of the first article cited should have been Burnell JM, Villamil MF, Uyeno BT, Scribner BH, rather than Burnell JM, Scribner BH, Uyeno BT, Villamil MF. The article is correct at NEJM.org. Interactive Perspective: Drug Development and FDA Approval, 1938–2013 (June 26, 2014;370:e39). The order of authors was incorrect; Dr. Darrow should have been listed first, and Dr. Kesselheim second. The article is correct at NEJM.org.

notices

This letter was published on December 24, 2014, at NEJM.org. 1. Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and

outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014;371:2092-100.

DOI: 10.1056/NEJMc1413685 Correspondence Copyright © 2014, 2015 Massachusetts Medical Society.

instructions for letters to the editor

Letters to the Editor are considered for publication, subject to editing and abridgment, provided they do not contain material that has been submitted or published elsewhere. Please note the following: • Letters in reference to a Journal article must not exceed 175 words (excluding references) and must be received within 3 weeks after publication of the article. • Letters not related to a Journal article must not exceed 400 words. • A letter can have no more than five references and one figure or table. • A letter can be signed by no more than three authors. • Financial associations or other possible conflicts of interest must be disclosed. Disclosures will be published with the letters. (For authors of Journal articles who are responding to letters, we will only publish new relevant relationships that have developed since publication of the article.) • Include your full mailing address, telephone number, fax number, and e-mail address with your letter. • All letters must be submitted at authors.NEJM.org. Letters that do not adhere to these instructions will not be considered. We will notify you when we have made a decision about possible publication. Letters regarding a recent Journal article may be shared with the authors of that article. We are unable to provide prepublication proofs. Submission of a letter constitutes permission for the Massachusetts Medical

588

Notices submitted for publication should contain a mailing address and telephone number of a contact person or department. We regret that we are unable to publish all notices ­received. Notices also appear on the Journal’s website (NEJM.org/medical-conference). The listings can be viewed in their entirety or filtered by specialty, location, or month. 9th World Congress on Controversies in Neurology The congress will be held in Budapest, Hungary, March 26–28. Contact ComtecMed, 53 Rothschild Blvd., P.O. Box 68, Tel Aviv, 6100001, Israel; or call (972) 3 5666166; or fax (972) 3 5666177; or e-mail [email protected]; or see http://www .comtecmed.com/cony.

FIRST INTERNATIONAL CRITICAL CARE MEDICINE CONFERENCE The conference will be held in Da Nang, Vietnam, April 13–17. It is presented by the Vietnam Association of Emergency, Critical Care Medicine and Medical Toxicology. The conference is supported by the Society of Critical Care Medicine. Contact Dr. Carl Bartecchi, 615 Dittmer Ave., Pueblo, CO 81005 or Dr. Hoang Huu Hieu, Intensive Care Unit, Da Nang Hospital, 50-52 Nguyen Van Linh St., Da Nang, Vietnam; or e-mail [email protected] or [email protected]; or call 0120 813 0561; or see http://www.2015ccmc.org.

International Academy of Cardiology Annual Scientific Sessions 2015 The “20th World Congress on Heart Disease” will be held in Vancouver, BC, Canada, July 25–27. Deadline for submission of abstracts is Feb. 10. Contact Dr. Asher Kimchi, International Academy of Cardiology, P.O. Box 17659, Beverly Hills, CA 90209; or call (310) 657 8777; or fax (310) 659 4781; or e-mail [email protected]; or see http://www.cardiologyonline.com.

n engl j med 372;6 nejm.org february 5, 2015

The New England Journal of Medicine Downloaded from nejm.org on November 5, 2015. For personal use only. No other uses without permission. Copyright © 2015 Massachusetts Medical Society. All rights reserved.

Interactive perspective: drug development and FDA approval, 1938-2013.

Interactive Perspective: Drug Development and FDA Approval, 1938-2013 (June 26, 2014;370:e39). The order of authors was incorrect; Dr. Darrow should h...
352KB Sizes 3 Downloads 8 Views